{
  "docId": "019de514-6ff5-7310-813b-bef8d5f9ec91",
  "docSlug": "dbbeae38634aeeee4a36f290777f18f9",
  "documentTitle": "Vivani Medical | Mergers and Acquisitions Presentation Deck | 27 slides",
  "authorId": "vivani-medical",
  "authorName": "Vivani Medical",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2022-10-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 4,
  "pageCount": 27,
  "prevPage": 3,
  "nextPage": 5,
  "slideType": "executive_summary",
  "function": "summarize",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de514-6ff5-7310-813b-bef8d5f9ec91/4",
  "deckHref": "/decks/019de514-6ff5-7310-813b-bef8d5f9ec91",
  "deckJsonHref": "/decks/019de514-6ff5-7310-813b-bef8d5f9ec91.json",
  "deckAnchorHref": "/decks/019de514-6ff5-7310-813b-bef8d5f9ec91#slide-4",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.88,
        "x": 0.07,
        "y": 0.2
      },
      "kind": "list",
      "text": "1. An innovative, clinical-stage, biopharmaceutical company that develops and manufactures novel, long-term therapeutic implants to treat chronic diseases.\n2. Biopharm Division (formerly Nano Precision Medical) develops tiny, drug implants that provide therapeutic levels of medicine over extended periods of time, guaranteeing medication adherence. NPM-119 (6-month GLP-1 implant candidate for Type 2 Diabetes) is Vivani's main focus.\n3. Neuromodulation Division (formerly Second Sight Medical Products) develops highly innovative medical implant candidates to treat blindness. Vivani is assessing strategic options for advancing Orion II, a cortical visual prosthesis designed to treat profound blindness.\n4. Vivani is well-positioned with new leadership and sufficient capital to support multiple milestones for NPM-119 while assessing strategic options for Orion II.",
      "attrs": null,
      "subkind": "numbered",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4e10968d-e014-40ed-8a07-b04457e1749b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "Vivani Medical, Inc.",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "09f9d0d7-a492-4465-ab59-591feec33376",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Executive summary",
      "slug": "executive-summary",
      "agent": null,
      "layer": "slide",
      "matchId": "7015bf6d-322c-4a46-b478-de76c7a189ad",
      "evidence": "This slide provides a brief overview of the company, Vivani Medical, Inc.",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}